Back to top
more

Henry Schein (HSIC)

(Real Time Quote from BATS)

$70.41 USD

70.41
464,324

-1.92 (-2.66%)

Updated Nov 5, 2024 10:28 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Catalent's (CTLT) Tie-Up to Accelerate Clinical Trial Timelines

by Zacks Equity Research

Catalent's (CTLT) latest collaboration is expected to leverage multiple services that reduce drug development timelines.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.

Shockwave Medical (SWAV) Launches New IVL Catheter in U.S.

by Zacks Equity Research

Shockwave Medical's (SWAV) latest U.S. launch is expected to serve a wider patient pool.

Here's Why You Should Retain Merit Medical (MMSI) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

PacBio's (PACB) Latest Offering to Enhance Genome Analysis

by Zacks Equity Research

PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

by Zacks Equity Research

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a concern.

The Zacks Analyst Blog Highlights Ameriprise Financial, Everest Re Group, Microchip Technology, Henry Schein and HSBC Holdings

by Zacks Equity Research

Ameriprise Financial, Everest Re Group, Microchip Technology, Henry Schein and HSBC Holdings are part of the Zacks top Analyst Blog.

Henry Schein (HSIC) Aids Growth of Ambulatory Surgery Centers

by Zacks Equity Research

Henry Schein (HSIC) joined ASCA as part of its commitment to augment the value of ambulatory surgery centers.

OPKO Health (OPK) to Develop EBV Vaccine With Latest Tie-Up

by Zacks Equity Research

OPKO Health's (OPK) entry into a worldwide license and collaboration agreement with Merck is expected to aid in developing a vaccine against EBV.

Here's Why You Should Retain NextGen (NXGN) Stock for Now

by Zacks Equity Research

NextGen's (NXGN) strong product portfolio and continued demand for its solutions raise optimism about the stock.

Henry Schein (HSIC) International Growth Solid, Dental Rebounds

by Zacks Equity Research

Henry Schein's (HSIC) distribution business boasts a wide global footprint with 61 distribution centers.

Urmimala Biswas headshot

5 Discounted Value Picks Based on PEG Ratio

by Urmimala Biswas

Here are five stocks that pass our screening criteria. These are HSIC, KR, BIDU, TOL and ACGL.

Nalak Das headshot

Fed May Stick to 25 bps Rate Hike After SVB Fiasco: 5 Picks

by Nalak Das

We have narrowed the search to select five companies that have strong potential for 2023. These are: AMP, RE, MCHP, HSIC and HSBC.

PerkinElmer (PKI) Completes Divestment, New Business Name in Q2

by Zacks Equity Research

PerkinElmer (PKI) completes separation of its businesses into two entities ¿¿¿ the AES business, and the Life Sciences and Diagnostics business.

HSIC or WST: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

HSIC vs. WST: Which Stock Is the Better Value Option?

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Is Henry Schein (HSIC) a Great Value Stock Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Best Value Stocks to Buy for March 8th

by Zacks Equity Research

MBGAF, FSBW and HSIC made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 8, 2023.

New Strong Buy Stocks for March 8th

by Zacks Equity Research

ASBFY, PLYA, HSII, APG and HSIC have been added to the Zacks Rank #1 (Strong Buy) List on March 8, 2023.

Best Growth Stocks to Buy for March 6th

by Zacks Equity Research

UGP, HSIC and DTEGY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 6, 2023.

New Strong Buy Stocks for March 6th

by Zacks Equity Research

URBN, BDC, DTEGY, HSIC and SVC have been added to the Zacks Rank #1 (Strong Buy) List on March 6, 2023.

Shaun Pruitt headshot

2 Medical Stocks to Buy Right Now

by Shaun Pruitt

There is always an essential need for healthcare and here are two Zacks Rank #1 (Strong Buy) medical stocks that investors should consider buying right now.

Best Growth Stocks to Buy for March 1st

by Zacks Equity Research

IFNNY, HSIC and LW made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 1, 2023.

Best Value Stocks to Buy for March 1st

by Zacks Equity Research

MBGAF, HSIC and EBR made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 1, 2023.

Urmimala Biswas headshot

5 Best PEG-Driven GARP Stocks to Grab Now

by Urmimala Biswas

Here are the five GARP stocks that qualify our screening criteria -- META, HSIC, ADI, HSBC, ACGL.